Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366705097> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4366705097 abstract "We aimed to investigate the mechanism of action of Yupingfeng capsule for combined allergic rhinitis and asthma syndrome via the toll-like receptor 4/nuclear factor-kappa B pathway. Rats were divided into normal, model, experimental and control groups. Combined allergic rhinitis and asthma syndrome model was established through sensitization with ovalbumin and aluminium hydroxide and intranasal instillation and atomization of ovalbumin. Then experimental and control groups were given Yupingfeng capsules and dexamethasone at 2 mg/kg by gavage once a day for 14 consecutive days, while normal and model groups were intraperitoneally injected with an equal dose of normal saline. Their nasal symptoms were scored and cell apoptosis in lung tissues was observed by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining. Serum levels of interleukin-5 and interleukin-13 were detected by enzyme-linked immunosorbent assay and toll-like receptor 4 and nuclear factor-kappa B expressions in lung and nasal mucosa tissues were measured by Western blotting. The score of nasal symptoms, levels of interleukin-5 and interleukin-13, cell apoptosis rate in lung tissues and expressions of toll-like receptor 4 and nuclear factor-kappa B were significantly lower in experimental and control groups than in model group (p<0.05). Yupingfeng capsule can obviously suppress the release of inflammatory factors and the apoptosis of cells as well as relieve the symptoms of combined allergic rhinitis and asthma syndrome rats probably by inhibiting the toll-like receptor 4/nuclear factor-kappa B pathway." @default.
- W4366705097 created "2023-04-24" @default.
- W4366705097 creator A5001658100 @default.
- W4366705097 creator A5035301095 @default.
- W4366705097 creator A5054566597 @default.
- W4366705097 creator A5057233052 @default.
- W4366705097 date "2022-01-01" @default.
- W4366705097 modified "2023-09-30" @default.
- W4366705097 title "Action Mechanism of Yupingfeng Capsule for Combined Allergic Rhinitis and Asthma Syndrome via the Toll-Like Receptor 4/Nuclear Factor-Kappa B Pathway" @default.
- W4366705097 doi "https://doi.org/10.36468/pharmaceutical-sciences.1111" @default.
- W4366705097 hasPublicationYear "2022" @default.
- W4366705097 type Work @default.
- W4366705097 citedByCount "0" @default.
- W4366705097 crossrefType "journal-article" @default.
- W4366705097 hasAuthorship W4366705097A5001658100 @default.
- W4366705097 hasAuthorship W4366705097A5035301095 @default.
- W4366705097 hasAuthorship W4366705097A5054566597 @default.
- W4366705097 hasAuthorship W4366705097A5057233052 @default.
- W4366705097 hasBestOaLocation W43667050971 @default.
- W4366705097 hasConcept C126322002 @default.
- W4366705097 hasConcept C134018914 @default.
- W4366705097 hasConcept C170493617 @default.
- W4366705097 hasConcept C185592680 @default.
- W4366705097 hasConcept C190283241 @default.
- W4366705097 hasConcept C203014093 @default.
- W4366705097 hasConcept C2776042228 @default.
- W4366705097 hasConcept C2776946954 @default.
- W4366705097 hasConcept C2777361909 @default.
- W4366705097 hasConcept C2778690821 @default.
- W4366705097 hasConcept C32046619 @default.
- W4366705097 hasConcept C55493867 @default.
- W4366705097 hasConcept C71924100 @default.
- W4366705097 hasConcept C74172505 @default.
- W4366705097 hasConcept C8891405 @default.
- W4366705097 hasConcept C98274493 @default.
- W4366705097 hasConceptScore W4366705097C126322002 @default.
- W4366705097 hasConceptScore W4366705097C134018914 @default.
- W4366705097 hasConceptScore W4366705097C170493617 @default.
- W4366705097 hasConceptScore W4366705097C185592680 @default.
- W4366705097 hasConceptScore W4366705097C190283241 @default.
- W4366705097 hasConceptScore W4366705097C203014093 @default.
- W4366705097 hasConceptScore W4366705097C2776042228 @default.
- W4366705097 hasConceptScore W4366705097C2776946954 @default.
- W4366705097 hasConceptScore W4366705097C2777361909 @default.
- W4366705097 hasConceptScore W4366705097C2778690821 @default.
- W4366705097 hasConceptScore W4366705097C32046619 @default.
- W4366705097 hasConceptScore W4366705097C55493867 @default.
- W4366705097 hasConceptScore W4366705097C71924100 @default.
- W4366705097 hasConceptScore W4366705097C74172505 @default.
- W4366705097 hasConceptScore W4366705097C8891405 @default.
- W4366705097 hasConceptScore W4366705097C98274493 @default.
- W4366705097 hasIssue "2" @default.
- W4366705097 hasLocation W43667050971 @default.
- W4366705097 hasOpenAccess W4366705097 @default.
- W4366705097 hasPrimaryLocation W43667050971 @default.
- W4366705097 hasRelatedWork W2014510410 @default.
- W4366705097 hasRelatedWork W2018368842 @default.
- W4366705097 hasRelatedWork W2033472167 @default.
- W4366705097 hasRelatedWork W2034583712 @default.
- W4366705097 hasRelatedWork W2063619316 @default.
- W4366705097 hasRelatedWork W2074821979 @default.
- W4366705097 hasRelatedWork W2114335715 @default.
- W4366705097 hasRelatedWork W2169225653 @default.
- W4366705097 hasRelatedWork W2407131039 @default.
- W4366705097 hasRelatedWork W2414846389 @default.
- W4366705097 hasVolume "85" @default.
- W4366705097 isParatext "false" @default.
- W4366705097 isRetracted "false" @default.
- W4366705097 workType "article" @default.